Acutus Medical Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $33.86 million
- Book Value:
- Revenue TTM:
- $15.76 million
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Acutus Medical Inc had its IPO on 2020-08-06 under the ticker symbol AFIB.
The company operates in the Healthcare sector and Medical Devices industry. Acutus Medical Inc has a staff strength of 338 employees.
Shares of Acutus Medical Inc opened at $0.81 at the start of the last trading session i.e. 2023-03-23.
The stocks traded within a range of $0.8 - $0.84, and closed at $0.81.
This is a +0.97% increase from the previous day's closing price.
A total volume of 37,675 shares were traded at the close of the day’s session.
In the last one week, shares of Acutus Medical Inc have slipped by -10.02%.
Acutus Medical Inc's Key Ratios
Acutus Medical Inc has a market cap of $33.86 million, indicating a price to book ratio of 0.3908 and a price to sales ratio of 1.462.
In the last 12-months Acutus Medical Inc’s revenue was $15.76 million with a gross profit of $-15662000 and an EBITDA of $-102651000. The EBITDA ratio measures Acutus Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Acutus Medical Inc’s operating margin was -693.78% while its return on assets stood at -43.81% with a return of equity of -89.82%.
In Q3, Acutus Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 20.8%.
Acutus Medical Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-2.4 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Acutus Medical Inc’s profitability.
Acutus Medical Inc stock is trading at a EV to sales ratio of 1.0881 and a EV to EBITDA ratio of 0.0654. Its price to sales ratio in the trailing 12-months stood at 1.462.
Acutus Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $114.63 million
- Total Liabilities
- $18.32 million
- Operating Cash Flow
- $5.85 million
- Capital Expenditure
- Dividend Payout Ratio
Acutus Medical Inc ended 2023 with $114.63 million in total assets and $0 in total liabilities. Its intangible assets were valued at $114.63 million while shareholder equity stood at $57.78 million.
Acutus Medical Inc ended 2023 with $0 in deferred long-term liabilities, $18.32 million in other current liabilities, 28000.00 in common stock, $-533422000.00 in retained earnings and $0.00 in goodwill. Its cash balance stood at $28.00 million and cash and short-term investments were $66.30 million. The company’s total short-term debt was $392,000 while long-term debt stood at $34.31 million.
Acutus Medical Inc’s total current assets stands at $93.89 million while long-term investments were $0.00 and short-term investments were $38.30 million. Its net receivables were $3.21 million compared to accounts payable of $4.64 million and inventory worth $14.60 million.
In 2023, Acutus Medical Inc's operating cash flow was $5.85 million while its capital expenditure stood at $755000.
Comparatively, Acutus Medical Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Acutus Medical Inc stock is currently trading at $0.81 per share. It touched a 52-week high of $2.19 and a 52-week low of $2.19. Analysts tracking the stock have a 12-month average target price of $2.21.
Its 50-day moving average was $1.36 and 200-day moving average was $1.09 The short ratio stood at 1.76 indicating a short percent outstanding of 0%.
Around 432.4% of the company’s stock are held by insiders while 3822.5% are held by institutions.
Frequently Asked Questions About Acutus Medical Inc
Similar Industry Stocks (Medical Devices)
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company’s product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.